CCK8 assays demonstrated that pharmacological inhibition of FASN and siRNA-mediated down-regulation of FASN inhibited proliferation of HCC cells, whereas transgene-mediated up-regulation of FASN had positive effect on HCC cells growth (Fig. S1C). This evidence concerns the gene FASN and hepatocellular carcinoma.